Druggable genome in attention deficit/hyperactivity disorder and
Druggable genome in attention deficit/hyperactivity disorder and
Transcriptome‐wide gene expression in a rat model of attention deficit hyperactivity disorder symptoms: Rats developmentally exposed to polychlorinated biphenyls - Sazonova - 2011 - American Journal of Medical Genetics Part B: Neuropsychiatric
FDA-Approved Drugs to Treat ADHD Journal of Psychosocial Nursing and Mental Health Services
The role of glutamate receptors in attention‐deficit/hyperactivity disorder: From physiology to disease - Huang - 2019 - American Journal of Medical Genetics Part B: Neuropsychiatric Genetics - Wiley Online Library
Workshop: Genes to Biology: Integrative Systematic Approaches for Revealing Biological Functions of Psychiatric Risk Genes and Alleles - National Institute of Mental Health (NIMH)
Genes, Free Full-Text
Tile plot of the association between druggable genes and ADHD (p
New research explores the unique effects of ADHD medications on Drosophila brain cells
Linking GWAS to pharmacological treatments for psychiatric disorders
Attention-Deficit Hyperactivity Disorder: Genetic, Pharmacogenetic, and Metabolomic Insights
Insights into attention-deficit/hyperactivity disorder from recent genetic studies, Psychological Medicine
Examining the shared etiology of psychopathology with genome-wide association studies
Pharos – A Torch to Use in Your Journey In the Dark Genome